Evidence map›Paper›PMID 39323018›Full record

ArticleAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc2024

Motor Vehicle Driving-Related Anxiety in Patients Undergoing Cardioverter Defibrillator Implantation and Cardiac Resynchronization Therapy With Defibrillators.

Shingo Moriguchi, Masahito Hitosugi, Yuzo Takeuchi, Takeshi Inoue, Shinsaku Takeda, Mineko Baba, Arisa Takeda, Mami Nakamura, Yasutaka Inuzuka

Abstract read
In one paragraph

Article in Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shingo MoriguchiDepartment of Legal Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu, Shiga, Japan.ORCID 0000-0002-9372-8628
Masahito HitosugiDepartment of Legal Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu, Shiga, Japan.ORCID 0000-0001-5243-8766
Yuzo TakeuchiDepartment of Cardiology, Shiga General Hospital, Moriyama, Shiga, Japan.
Takeshi InoueDepartment of Cardiology, Shiga General Hospital, Moriyama, Shiga, Japan.
Shinsaku TakedaDepartment of Cardiology, Shiga General Hospital, Moriyama, Shiga, Japan.
Mineko BabaCenter of Integrated Medical Research, Keio University, School of Medicine, Shinjuku, Tokyo, Japan.
Arisa TakedaDepartment of Legal Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu, Shiga, Japan.
Mami NakamuraDepartment of Legal Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu, Shiga, Japan.
Yasutaka InuzukaDepartment of Cardiology, Shiga General Hospital, Moriyama, Shiga, Japan.

Funding

Japanese Council of Traffic Science
6 · The paper itself

Abstract

backgroundReducing anxiety about motor vehicle driving in patients receiving implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillators is important not only for improving quality of life but also for preventing vehicle collisions owing to driver distraction. This study aimed to clarify the driving-related anxiety of patients with these defibrillators and the factors that predict such anxiety.

methodsWe conducted a cross-sectional survey using a self-administered questionnaire of patients who had been driving a vehicle after device implantation at a general hospital between August 2018 and November 2019.

resultsThe mean age was 60.8 ± 12.6 years. The reasons for implantation were primary prevention in 47 patients and secondary prevention in 30 patients. A total of 16 patients experienced anxiety about driving and 61 did not. Significantly more younger patients (mean age of 50.4 vs. 63.6 years, p < 0.001) and those with implantable cardioverter defibrillators had anxiety (100% vs. 73.8%, p = 0.02). Multivariable analysis indicated that age was the only independent factor that predicted driving-related anxiety (odds ratio, 0.937; 95% confidence interval, 0.883-0.993).

conclusionsIdentifying and addressing driving-related anxiety in patients (particularly young patients) with defibrillators is important in preventing motor vehicle collisions and improving quality of life.

Indexed as

AnxietyAutomobile DrivingCardiac Resynchronization TherapyDefibrillators, ImplantableAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedQuality of LifeSurveys and Questionnairesanxietycardiac resynchronization therapyimplantable cardioverter defibrillatorslawmotor vehicle driving

Identifiers

PMID39323018
PMCPMC11424494

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.